Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex M Aronov

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Current Topics in Medicinal Chemistry|September 11, 2008
Ligand structural aspects of hERG channel blockadeAlex M Aronov
Methods in Molecular Biology (Clifton, N.J.)|October 3, 2002
Design of virtual combinatorial librariesAlex M Aronov
Journal of Medicinal Chemistry|December 13, 2006
Common pharmacophores for uncharged human ether-a-go-go-related gene (hERG) blockersAlex M Aronov
Drug Discovery Today|February 19, 2005
Predictive in silico modeling for hERG channel blockersAlex M Aronov
Current Opinion in Drug Discovery & Development|January 5, 2008
Tuning out of hERGAlex M Aronov
Bioorganic & Medicinal Chemistry|April 15, 2004
A model for identifying HERG K+ channel blockersAlex M Aronov, Brian B Goldman
Proteins|August 25, 2004
A minimalist approach to fragment-based ligand design using common rings and linkers: application to kinase inhibitorsAlex M Aronov, Guy W Bemis
Journal of Medicinal Chemistry|October 29, 2004
Toward a pharmacophore for kinase frequent hittersAlex M Aronov, Mark A Murcko
Nature Reviews. Drug Discovery|October 28, 2017
Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indicationsHsin-Pei Shih, Xiaodan Zhang, Alex M Aronov
Nature Reviews. Drug Discovery|December 16, 2017
Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indicationsHsin-Pei Shih, Xiaodan Zhang, Alex M Aronov
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Current Topics in Medicinal Chemistry|September 11, 2008
Ligand structural aspects of hERG channel blockadeAlex M Aronov
Methods in Molecular Biology (Clifton, N.J.)|October 3, 2002
Design of virtual combinatorial librariesAlex M Aronov
Journal of Medicinal Chemistry|December 13, 2006
Common pharmacophores for uncharged human ether-a-go-go-related gene (hERG) blockersAlex M Aronov
Drug Discovery Today|February 19, 2005
Predictive in silico modeling for hERG channel blockersAlex M Aronov
Current Opinion in Drug Discovery & Development|January 5, 2008
Tuning out of hERGAlex M Aronov
Bioorganic & Medicinal Chemistry|April 15, 2004
A model for identifying HERG K+ channel blockersAlex M Aronov, Brian B Goldman
Proteins|August 25, 2004
A minimalist approach to fragment-based ligand design using common rings and linkers: application to kinase inhibitorsAlex M Aronov, Guy W Bemis
Journal of Medicinal Chemistry|October 29, 2004
Toward a pharmacophore for kinase frequent hittersAlex M Aronov, Mark A Murcko
Nature Reviews. Drug Discovery|October 28, 2017
Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indicationsHsin-Pei Shih, Xiaodan Zhang, Alex M Aronov
Nature Reviews. Drug Discovery|December 16, 2017
Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indicationsHsin-Pei Shih, Xiaodan Zhang, Alex M Aronov
Pageof 3